G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
| DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
| XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
| Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
| ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |